SEARCH

SEARCH BY CITATION

References

  • 1
    Hanninen T, Koivisto K, Reinikainen KJ, Helkala EL, Soininen H, Mykkanen L, Laakso M, Riekkinen PJ. Prevalence of aging-associated cognitive decline in an elderly population. Age Aging 1996; 25: 201205.
  • 2
    Small SA, Stern Y, Tang M, Mayeux R. Selective decline in memory function among healthy elderly. Neurology 1999; 52: 392396.
  • 3
    Driscoll I, Hamilton DA, Yeo RA, Brooks WM, Sutherland RJ. Visual navigation in humans: the impact of age, sex, and hormones. Horm Behav 2005; 47: 326335.
  • 4
    Salthouse TA. Mediation of adult age differences in cognition by reduction in working memory and speed of processing. Psychol Sci 1991; 2: 179183.
    Direct Link:
  • 5
    Sherwin BB. Estrogen and cognition in women. Endocrine Rev 2003; 24: 133151.
  • 6
    Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. J Am Med Assoc 2004; 291: 29592968.
  • 7
    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, for the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. J Am Med Assoc 2003; 289: 26512662.
  • 8
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, for the Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. J Am Med Assoc 2004; 291: 29472958.
  • 9
    Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. J Am Med Assoc 2002; 288: 21702172.
  • 10
    Maki PM. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 2006; 138: 10271030.
  • 11
    Sherwin BB. Estrogen and memory in women: how can we reconcile the findings? Horm Behav 2005; 15: 3748.
  • 12
    Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dentritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990; 10: 12861291.
  • 13
    Adams MM, Shah RA, Janssen WGM, Morrison JH. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. PNAS 2001; 98: 80718076.
  • 14
    Silva I, Mello LEAM, Freymuller E, Haidar MA, Baracat EC. Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats. Menopause 2003; 10: 406411.
  • 15
    Hao J, Janssen WGM, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp P, Kordower IH, Hof PR, Morrison JH. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 2003; 465: 540550.
  • 16
    Hao J, Rapp PR, Leffler AE, Leffler SR, Janssen WGM, Lou W, McKay H, Roberts JA, Wearne SL, Hof PR, Morrison JH. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 2006; 26: 25712578.
  • 17
    Jezierski MK, Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging 2001; 22: 311321.
  • 18
    Savonenko AV, Markowska AL. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. J Neurosci 2003; 119: 821830.
  • 19
    Gibbs RN. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000; 21: 107116.
  • 20
    Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period ovarian hormone deprivation. Endocrinology 2006; 147: 607614.
  • 21
    Lacreuse A, Wilson ME, Herndon JG. Estradiol, but not raloxifene, improves aspects of spatial working memory in aged, ovariectomized rhesus monkeys. Neurobiol Aging 2002; 23: 589600.
  • 22
    Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates. J Neurosci 2005; 138: 859867.
  • 23
    Rapp PR, Morrision JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 2003; 23: 57085714.
  • 24
    Tinkler GP, Voytko ML. Estrogen modulates cognitivre and cholinergic processes in surgically menopausal monkeys. Prog Neuro-Psychopharm Biol Psychiatry 2005; 29: 423431.
  • 25
    Matthews KA, Cauley J, Yaffe K, Zmuda JM. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999; 47: 518523.
  • 26
    MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP, Taylor AW. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 2006; 13: 2836.
  • 27
    Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006; 91: 18021810.
  • 28
    Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002; 143: 205212.
  • 29
    Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC. Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County Study. J Am Med Assoc 2002; 288: 21232129.
  • 30
    Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76: 103105.
  • 31
    Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Earlypostmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005; 12: 1217.
  • 32
    Duka I, Tasker R, McGowan JF. The effects of a 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 2000; 149: 129139.
  • 33
    Yaffe K, Lui L-Y, Grady D, Cauley J, Kramer J, Cummings SR. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 2000; 356: 708712.
  • 34
    Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson JC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wenda J, Wallace R, Wassertheil-Smoller S. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2004; 291: 17011712.
  • 35
    Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA. Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Int Med 2006; 166: 10271032.